DocBot
About DocBot
Docbot, Inc. was a pioneering artificial intelligence (AI) technology company dedicated to advancing gastrointestinal (GI) diagnostics and care. Its core offering, the UltivisionAI™ platform, was designed to provide real-time image analysis during endoscopic procedures such as colonoscopies. For gastroenterologists, this meant an AI-assisted tool capable of enhancing the detection of polyps, lesions, and various GI diseases, including Barrett’s esophagus and ulcerative colitis. The platform aimed to augment human capabilities, improving diagnostic accuracy and efficiency, while also streamlining clinical workflows through automated reporting and data-driven analytics.
The company’s mission was to revolutionize GI care by providing powerful AI-assisted image analysis solutions. Docbot collaborated with major pharmaceutical companies, such as Eli Lilly, to explore applications like predicting the severity of ulcerative colitis from endoscopy videos, showcasing its commitment to leveraging AI for deeper clinical insights and improved patient outcomes. The technology was developed to integrate with existing IT systems, aiming to make documentation and billing more efficient, track quality indicators like withdrawal time, and ultimately contribute to earlier detection and prevention of GI cancers.
It is important for physicians to note that Docbot’s intellectual property and assets were strategically acquired by Satisfai Health, Inc. in November 2022. Following this acquisition, key technical employees from Docbot transitioned to Satisfai Health, indicating an integration of Docbot’s innovative AI-driven GI endoscopy solutions into Satisfai Health’s broader product roadmap. Therefore, while the UltivisionAI platform and its underlying technology continue to evolve, they are now part of Satisfai Health’s offerings.
Focus Areas
Business Intelligence
| Key Investors | Khosla Ventures, Bold Capital Partners, Collaborative Fund, Y Combinator, Bessemer Venture Partners, Expert Dojo, Incisive Ventures, Mayfield, Scale Asia Ventures, The Valley Fund, Think + Ventures, Ankush Gera, Kunal Shah, Boutique Venture Partners, Lightbridge Ventures, Fenox Venture Capital, Titan Angels |
| Partnerships | Eli Lilly (for inflammatory bowel disease and ulcerative colitis), UCI Medical Center, Gastro Health |
| Acquisitions | Acquired by Satisfai Health in November 2022 |
| Technology | UltivisionAI platform (AI-powered software for real-time image analysis, automated reporting, and analytics, machine learning, computer vision) |
What Physicians Need to Know
DocBot's UltivisionAI platform offers gastroenterologists real-time, AI-powered assistance during endoscopy, potentially increasing adenoma detection rates and reducing the risk of missed lesions. The system's ability to optically detect precancerous polyps in fractions of seconds, compared to traditional two-week pathology processes, can significantly expedite diagnosis and treatment planning, while also reducing associated costs. Furthermore, its automated reporting features can streamline clinical workflows, freeing up valuable physician time. The continuous learning nature of the AI means its performance is expected to improve over time, offering increasingly accurate and sensitive detection. Physicians can anticipate enhanced diagnostic accuracy and more objective methods for managing various GI conditions, including colon cancer, Barrett's esophagus, and ulcerative colitis.
Specific integration partners or detailed integration methods for DocBot's GI endoscopy AI platform (UltivisionAI) are not explicitly detailed in the provided search results. The company focuses on integrating its AI directly into the endoscopy workflow for real-time analysis.
Products by DocBot
What the Web Says
DocBot (also referred to as DocsBot AI) is an AI-powered tool primarily designed to create chatbots from existing documentation to automate customer support and streamline document management. It is praised for its user-friendly interface, ease of integration, and ability to provide accurate, context-specific answers. The company also offers a medical coding AI tool called DocBot, which focuses on automating diagnosis coding and improving accuracy for healthcare providers.
Overall: PositiveStrengths
- User-friendly interface and easy integration for chatbot creation.
- Accurate and context-specific answers from chatbots, reducing hallucinations.
- Automates repetitive tasks and streamlines document management, saving time and increasing productivity.
- Supports a wide range of content sources for training chatbots, including websites, files, and YouTube transcripts.
- Medical coding AI improves risk adjustment accuracy, reduces audit risk, and increases provider satisfaction.
- Offers API options for seamless integration with other tools.
Limitations
- Some features are limited to premium plans, and pricing can be expensive.
- Chatbot accuracy is highly dependent on the quality and structure of the source documentation.
- Advanced automation features may require technical expertise to configure.
- Limited customization options for chatbot appearance and behavior.
- May experience occasional lagging, bugs, or crashes.
- Lack of native live chat interface or agent inbox, meaning it's not a full-service support platform.
Based on reviews from: G2, Product Hunt, DocBot Medical Coding AI Website, Reddit, SaaSInspector, Bright SEO Tools, WP Mayor
Last updated: 2026-08-22
Videos
News, demos, and interviews about DocBot.
Videos load interactively. If none appear, search YouTube for DocBot →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded DocBot.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]